Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by HarveyTwoface on Mar 05, 2021 11:46am

Naked shorting

Anonymous can naked short this to 2 dollars if they want. This will repeat over and over again (no matter what news they throw out) until the company is taken over by big pharma. This company will never see Nasdaq. Welcome to Canada where naked shorting can f**k the entire economy.
Comment by Stoxxhp on Mar 05, 2021 11:51am
This post has been removed in accordance with Community Policy
Comment by HarveyTwoface on Mar 05, 2021 12:07pm
Yes, Dans famous words repeated over and over everytime anyone asks - "w..w..ww..wwweeee have nice optionality". Anyone who believe in that type of fairytale should go back to sleep. Otherwise wake up, my friend.
Comment by Actuarial on Mar 05, 2021 12:02pm
It would take only a few seconds for ATE to run above $7 again once Dan announced ATE targets Nasdaq uplisting within xx weeks/months. For now, who cares Nasdaq when ATE has enough cash in bank? Keep in mind, ATE is a drug development company but not a company playing financial tools. The finish line for ATE is to recieve FDA approval of 346, 352, 340, and the unamed IBD pipeline. While day ...more  
Comment by Marky1 on Mar 05, 2021 12:06pm
Well said ACT! Exactly right
Comment by HarveyTwoface on Mar 05, 2021 12:12pm
And shorted back again as soon as they announce any positive news. Learn from history.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse